- Home
- WBD vs TEVA Comparison
WBD vs TEVA Comparison
Compare WBD & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBD
- TEVA
- Stock Information
- Founded
- WBD 1923
- TEVA 1901
- Country
- WBD United States
- TEVA Israel
- Employees
- WBD N/A
- TEVA N/A
- Industry
- WBD Cable & Other Pay Television Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- WBD Telecommunications
- TEVA Health Care
- Exchange
- WBD Nasdaq
- TEVA Nasdaq
- Market Cap
- WBD 25.7B
- TEVA 23.7B
- IPO Year
- WBD N/A
- TEVA N/A
- Fundamental
- Price
- WBD $10.62
- TEVA $17.83
- Analyst Decision
- WBD Buy
- TEVA Buy
- Analyst Count
- WBD 23
- TEVA 7
- Target Price
- WBD $11.71
- TEVA $22.71
- AVG Volume (30 Days)
- WBD 25.6M
- TEVA 12.1M
- Earning Date
- WBD 02-27-2025
- TEVA 01-29-2025
- Dividend Yield
- WBD N/A
- TEVA N/A
- EPS Growth
- WBD N/A
- TEVA N/A
- EPS
- WBD N/A
- TEVA N/A
- Revenue
- WBD $39,578,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- WBD N/A
- TEVA $5.74
- Revenue Next Year
- WBD $0.51
- TEVA $4.46
- P/E Ratio
- WBD N/A
- TEVA N/A
- Revenue Growth
- WBD N/A
- TEVA 4.40
- 52 Week Low
- WBD $6.64
- TEVA $11.83
- 52 Week High
- WBD $12.70
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- WBD 56.95
- TEVA 29.76
- Support Level
- WBD $10.09
- TEVA $21.36
- Resistance Level
- WBD $10.56
- TEVA $22.40
- Average True Range (ATR)
- WBD 0.30
- TEVA 0.72
- MACD
- WBD 0.07
- TEVA -0.49
- Stochastic Oscillator
- WBD 94.35
- TEVA 6.46
About WBD Warner Bros. Discovery Inc. Series A
Warner Bros. Discovery was formed in 2022 through the combination of WarnerMedia and Discovery Communications. It operates in three global business segments: studios, networks, and direct-to-consumer. Warner Bros. Pictures is the crown jewel of the studios business, producing, distributing, and licensing movies and television shows. The networks business consists of basic cable networks, such as CNN, TNT, TBS, Discovery, HGTV, and the Food Network. Direct-to-consumer includes HBO and the firm's streaming platforms, which have now been consolidated to Max and Discovery+. Much of the DTC content is created within the firm's other two business segments. Each segment operates with a global reach, with Max available in over 60 countries.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.